Appili Therapeutics to Attend BARDA Innovation Symposium 2025
Highlights Government-Funded Pipeline and Expanding Role of Public-Private Partnerships in Biodefense Innovation HALIFAX, Nova Scotia, Oct. 22, 2025 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTC Pink: APLIF) ("Appili" or the "Company") today ann
(Financial Post, 2025-10-22T11:21:44Z)